Mustang Bio Inc. (MBIO) Financial Statements (2024 and earlier)

Company Profile

Business Address 377 PLANTATION STREET
WORCESTER, MA 01605
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

3/31/2024
MRQ
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments6,234,00075,656,000109,618,00097,804,00061,413,00034,073,000
Cash and cash equivalents6,234,00075,656,000109,618,00097,804,00061,413,00016,469,000
Short-term investments      17,604,000
Restricted cash and investments  1,000,0001,000,0001,000,0001,000,000 
Receivables      37,000
Prepaid expense      1,015,000
Other undisclosed current assets5,112,0002,196,0001,088,000730,000650,000 
Total current assets:11,346,00078,852,000111,706,00099,534,00063,063,00035,125,000
Noncurrent Assets
Operating lease, right-of-use asset1,566,0002,918,0001,050,0001,088,0001,196,000
Property, plant and equipment3,218,0009,391,00011,052,0008,028,0007,936,0006,858,000
Restricted cash and investments750,0001,000,0001,000,0001,000,0001,000,000500,000
Other noncurrent assets833,000261,000362,000250,000250,000271,000
Other undisclosed noncurrent assets 29,000     
Total noncurrent assets:6,396,00013,570,00013,464,00010,366,00010,382,0007,629,000
TOTAL ASSETS:17,742,00092,422,000125,170,000109,900,00073,445,00042,754,000
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:14,017,00013,731,0009,744,0008,747,0005,668,0005,381,000
Accounts payable6,322,0006,833,0003,512,0003,518,0001,877,000 
Other undisclosed accounts payable and accrued liabilities7,695,0006,898,0006,232,0005,229,0003,791,0005,381,000
Debt    278,0001,507,000 
Due to related parties766,000723,000490,000596,000 
Other undisclosed current liabilities1,354,000612,000348,000  236,000
Total current liabilities:15,371,00015,109,00010,815,0009,515,0007,771,0005,617,000
Noncurrent Liabilities
Long-term debt and lease obligation  27,436,0001,685,0001,950,00014,022,000 
Long-term debt, excluding current maturities  27,436,000  12,179,000 
Liabilities, other than long-term debt2,248,0003,604,000270,000  741,000
Accounts payable and accrued liabilities      741,000
Deferred revenue270,000270,000270,000  
Operating lease, liability1,978,0003,334,0001,685,0001,950,0001,843,000
Total noncurrent liabilities:2,248,00031,040,0001,955,0001,950,00014,022,000741,000
Total liabilities:17,619,00046,149,00012,770,00011,465,00021,793,0006,358,000
Equity
Equity, attributable to parent, including:123,00046,273,000112,400,00098,435,00051,652,00036,396,000
Common stock    7,0004,0003,000
Common stock, value, subscriptions 591,0001,109,0004,329,0007,939,0004,923,0002,085,000
Additional paid in capital380,502,000374,522,000359,906,000275,963,000172,184,000113,378,000
Accumulated deficit(380,971,000)(329,369,000)(251,844,000)(185,474,000)(125,459,000)(79,070,000)
Other undisclosed equity, attributable to parent1,00011,0009,000   
Total equity:123,00046,273,000112,400,00098,435,00051,652,00036,396,000
TOTAL LIABILITIES AND EQUITY:17,742,00092,422,000125,170,000109,900,00073,445,00042,754,000

Income Statement (P&L) (USD)

3/31/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Operating expenses(49,260,000)(76,159,000)(66,723,000)(56,806,000)(45,885,000)(31,223,000)
Operating loss:(49,260,000)(76,159,000)(66,723,000)(56,806,000)(45,885,000)(31,223,000)
Nonoperating income (expense)(2,342,000)(1,366,000)353,000(3,209,000)(504,000)561,000
Other nonoperating income (expense)  353,000   
Interest and debt expense(4,109,000)(3,359,000) (3,917,000)(1,767,000)(8,000)
Loss from continuing operations:(55,711,000)(80,884,000)(66,370,000)(63,932,000)(48,156,000)(30,670,000)
Loss before gain (loss) on sale of properties:(66,370,000)(63,932,000)(48,156,000)(30,670,000)
Net loss:(55,711,000)(80,884,000)(66,370,000)(63,932,000)(48,156,000)(30,670,000)
Other undisclosed net income attributable to parent4,109,0003,359,000 3,917,0001,767,0008,000
Net loss available to common stockholders, diluted:(51,602,000)(77,525,000)(66,370,000)(60,015,000)(46,389,000)(30,662,000)

Comprehensive Income (USD)

3/31/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net loss:(55,711,000)(80,884,000)(66,370,000)(63,932,000)(48,156,000)(30,670,000)
Comprehensive loss, net of tax, attributable to parent:(55,711,000)(80,884,000)(66,370,000)(63,932,000)(48,156,000)(30,670,000)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: